Early research (Phase 1)Not Yet RecruitingNCT07595965
What this trial is testing
Evaluate the Safety and Tolerability of CE211NS21 in Patients With AQP4-IgG-positive NMOSD Relapse
Who this might be right for
Neuromyelitis Optica Spectrum Disorder Relapse
Corestemchemon, Inc. 6